Journal article icon

Journal article

In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide.

Abstract:
Multiple sclerosis is a disease of the central nervous system that is associated with leukocyte recruitment and subsequent inflammation, demyelination and axonal loss. Endothelial vascular cell adhesion molecule-1 (VCAM-1) and its ligand, alpha4beta1 integrin, are key mediators of leukocyte recruitment, and selective inhibitors that bind to the alpha4 subunit of alpha4beta1 substantially reduce clinical relapse in multiple sclerosis. Urgently needed is a molecular imaging technique to accelerate diagnosis, to quantify disease activity and to guide specific therapy. Here we report in vivo detection of VCAM-1 in acute brain inflammation, by magnetic resonance imaging in a mouse model, at a time when pathology is otherwise undetectable. Antibody-conjugated microparticles carrying a large amount of iron oxide provide potent, quantifiable contrast effects that delineate the architecture of activated cerebral blood vessels. Their rapid clearance from blood results in minimal background contrast. This technology is adaptable to monitor the expression of endovascular molecules in vivo in various pathologies.
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1038/nm1631

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Oncology
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
RDM
Sub department:
RDM Cardiovascular Medicine
Role:
Author


Journal:
Nature medicine More from this journal
Volume:
13
Issue:
10
Pages:
1253-1258
Publication date:
2007-10-01
DOI:
EISSN:
1546-170X
ISSN:
1078-8956


Language:
English
Keywords:
Pubs id:
pubs:105273
UUID:
uuid:7e5d8bb6-47f4-485b-8468-6a1e1ef89c52
Local pid:
pubs:105273
Source identifiers:
105273
Deposit date:
2012-12-19

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP